Cargando…
Randomized supplementation of 4000 IU vitamin D(3) daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial
BACKGROUND: Low 25-hydroxyvitamin D (25OHD) levels (< 75 nmol/l) are inversely associated with anemia prevalence. Since anemia and low 25OHD levels are common in patients with heart failure (HF), we aimed to investigate whether vitamin D supplementation can reduce anemia prevalence in advanced HF...
Autores principales: | Ernst, J. B., Prokop, S., Fuchs, U., Dreier, J., Kuhn, J., Knabbe, C., Berthold, H. K., Pilz, S., Gouni-Berthold, I., Gummert, J. F., Börgermann, J., Zittermann, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569566/ https://www.ncbi.nlm.nih.gov/pubmed/28835271 http://dx.doi.org/10.1186/s12937-017-0270-5 |
Ejemplares similares
-
Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial
por: Zittermann, Armin, et al.
Publicado: (2018) -
A 3 year post‐intervention follow‐up on mortality in advanced heart failure (EVITA vitamin D supplementation trial)
por: Zittermann, Armin, et al.
Publicado: (2020) -
Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials
por: Zittermann, Armin, et al.
Publicado: (2023) -
Circulating 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Concentrations and Postoperative Infections in Cardiac Surgical Patients: The CALCITOP-Study
por: Zittermann, Armin, et al.
Publicado: (2016) -
Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device
por: Zittermann, Armin, et al.
Publicado: (2016)